Successful management of vesicouterine fistula by luteinizing hormone-releasing hormone analog.
Vesicouterine fistula is a rare complication of cesarean section. Although surgical repair was mandatory for the management of the fistula previously, a recent review showed high efficacy of hormonal manipulation by the induction of amenorrhea. Herein, we report a new case of vesicouterine fistula secondary to cesarean section successfully treated by luteinizing hormone-releasing hormone analog for 6 months. Conservative hormonal treatment for vesicouterine fistula caused by cesarean section should be considered before surgical repair.
Yokoyama
Minato
M
Department of Urology, East Tokyo Metropolitan Hospital, Tokyo, Japan. mntykym.uro@tmd.ac.jp
Arisawa
Chizuru
C
Ando
Masao
M
D000328:Adult; D003558:Cystoscopy; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives*; D006801:Humans; D007279:Injections, Subcutaneous; D016729:Leuprolide / Q000008:administration & dosage / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D001747:Urinary Bladder Fistula / Q000175:diagnosis / Q000188:drug therapy*; D014591:Uterine Diseases / Q000175:diagnosis / Q000188:drug therapy*
D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide